Surgery Partners (NASDAQ: SGRY) Rule 144 notice: 14,574 shares from vesting

Rhea-AI Filing Summary

Surgery Partners, Inc. filed a Rule 144 notice to sell 14,574 common shares, listed as equity vesting transactions on 02/28/2026 (2,939 shares) and 03/02/2026 (11,635 shares).

Shares outstanding were 129,419,836 as of 03/06/2026, as shown in the excerpt.

Insights

Securities Compliance Analyst

Routine Rule 144 notice for equity vesting; not a market-moving sale.

This filing lists 14,574 common shares tied to equity vesting events on 02/28/2026 and 03/02/2026

The excerpt shows shares outstanding 129,419,836 as of 03/06/2026; the filing is a procedural resale notice rather than an immediate, large‑scale disposition.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	14574	201719.01	129419836	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/28/2026	equity vesting	Surgery Partners, Inc.			2939	02/28/2026	equity compensation
common	03/02/2026	equity vesting	Surgery Partners, Inc.			11635	03/02/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Surgery Partners' Rule 144 filing (SGRY) disclose?

The filing discloses a proposed sale of 14,574 common shares arising from equity vesting on 02/28/2026 and 03/02/2026, according to the excerpt.

How many shares are listed for sale under the Rule 144 notice for SGRY?

The notice lists a total of 14,574 shares, split as 2,939 shares on 02/28/2026 and 11,635 shares on 03/02/2026 in the provided excerpt.

Does the filing show Surgery Partners' outstanding shares (SGRY)?

Yes; the excerpt shows 129,419,836 shares outstanding as of 03/06/2026, presented as a context figure in the filing content.

Is this Rule 144 filing a sign of a large insider sale for SGRY?

No; the filing records 14,574 vested shares, a small fraction of the reported 129,419,836 outstanding shares, and appears to be a routine resale notice.

What causes the shares listed in the SGRY Rule 144 filing?

The shares are tied to equity vesting events for Surgery Partners on the dates 02/28/2026 and 03/02/2026, as stated in the excerpt.